9 results on '"Flamant Y"'
Search Results
2. 5-Fluorouracil and Cisplatin Therapy After Palliative Surgical Resection of Squamous Cell Carcinoma of the Esophagus
- Author
-
Pouliquen, X, Levard, H, Pujol, Jp, Mcgee, K, Fingerhut, A, Langlois Zantin, O, Vacher, B, Urbajtel, M, Ley, F, Brassier, D, Elhadad, A, Sage, M, Lozach, P, Gayral, F, Millat, B, Chipponi, J, Flamant, Y, Hay, Jm, Zeitoun, G, Grandjean, M, Fagniez, Pl, Rotman, N, Rouffet, F, Bugnon, Py, Gautier Benoit, C, Desrousseaux, B, Huguier, M, Lacaine, F, Oberlin, P, Rea, Silvio, Bokobza, B, Michot, F, Teniere, P, and Testart, J.
- Subjects
Chemotherapy ,medicine.medical_specialty ,Palliative care ,business.industry ,Esophageal disease ,medicine.medical_treatment ,Cancer ,PREOPERATIVE RADIOTHERAPY, PHASE-II, CHEMOTHERAPY, CANCER ,CHEMOTHERAPY ,medicine.disease ,CANCER ,Surgery ,medicine.anatomical_structure ,Epidermoid carcinoma ,PHASE-II ,Carcinoma ,Medicine ,Radical surgery ,Esophagus ,business ,PREOPERATIVE RADIOTHERAPY - Abstract
BACKGROUND: The curative rate of surgical resection of squamous cell carcinoma of the esophagus is low. Reports on the efficacy of preoperative and postoperative chemotherapy are conflicting or have included limited disease or radical surgery alone. OBJECTIVE: The authors' objective was to study the results of chemotherapy on the duration and quality of survival in patients who have undergone palliative surgical resection for esophageal squamous cell carcinoma. PATIENTS AND METHODS: Of 124 patients with histologically proven esophageal squamous cell carcinoma situated more than 5 cm from the upper end of the esophagus, 4 patients were withdrawn for failure to comply with the protocol. The remaining 120 patients, 116 males and 4 females (mean age, 57 +/- 9 years), were randomly assigned to either a control group who were to receive no chemotherapy (68 patients) or to a group who were to be treated with chemotherapy (52 patients). Patients were subdivided into two strata as follows: (1) stratum I, complete resection of the tumor with lymph node involvement (62 patients) and (2) stratum ii, incomplete resection leaving macroscopic tumor tissue in situ or with metastases. Noninclusion criteria were histologically proven tracheobronchial involvement, esotracheal fistula, major alteration of general health status (Karnofsky score 30% of parenchyma) hepatic metastasis, peritoneal carcinomatosis, associated or previously treated upper airway cancer, or, conversely, complete resection of tumor without lymph node involvement. Chemotherapy was given in 5-day courses, every 28 days, with a maximum of 8 courses. Cisplatin was administered either as a single dose of 100 mg/m2 at the beginning of the course or as 20 mg/m2/day for 5 days given over 3 hours. 5- Fluorouracil (5-FU) (100 mg/m2/day) was infused over 24 hours for 5 days. The duration of treatment ranged from 6 to 8 months. The main aim was to establish median survival and actuarial survival curves. The subsidiary aim was to evaluate quality of survival as judged by complications due to treatment and the duration of autonomous oral feeding, that is, without palliative endoscopic treatment. No difference in survival was noted between the two groups, overall (median, 14 months), or between the strata. Conversely, significantly more patients in the treated group had hematologic, neurologic, and renal complications compared with the control group. Four patients died of complications of chemotherapy. The duration of autonomous oral alimentation was exactly the same in both groups (median, 12 + months). CONCLUSION: The results of this study suggest that 5-FU and cisplatin are not useful for patients with squamous cell carcinoma of the esophagus who have not undergone curative resection.
- Published
- 1996
- Full Text
- View/download PDF
3. Total Versus Subtotal Gastrectomy for Adenocarcinoma of the Gastric Antrum
- Author
-
GOUZI, J. L., primary, HUGUIER, M., additional, FAGNIEZ, P. L., additional, LAUNOIS, B., additional, FLAMANT, Y., additional, LACAINE, F., additional, PAQUET, J. C., additional, and HAY, J. M., additional
- Published
- 1989
- Full Text
- View/download PDF
4. SURGICAL TREATMENT OF SEVERE CHRONIC HEPATIC ENCEPHALOPATHY.
- Author
-
Boudet, M. J., Dermesropian, J. S., Zeitoun, G., Hay, J. M., and Flamant, Y.
- Published
- 1993
5. DETECTION OF LIVER METASTASES FROM COLORECTAL CANCER BY CT DURING ARTERIAL PORTOGRAPHY, INTRAOPERATIVE US AND PALPATION DURING LIVER VASCULAR EXCLUSION.
- Author
-
Boudet, M. J., Zeitoun, G., Soyer, P., Hay, J. M., and Flamant, Y.
- Published
- 1993
6. SHUNTING PROCEDURES IN BUDD-CHIARI SYNDROME: LONG-TERM RESULTS.
- Author
-
Boudet, M. J., Zeitoun, G., Hay, J. M., and Flamant, Y.
- Published
- 1993
7. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.
- Author
-
Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, Hay JM, Flamant Y, and Msika S
- Subjects
- Adult, Aged, Combined Modality Therapy, Female, Humans, Hyperthermia, Induced, Infusions, Parenteral, Liver Neoplasms secondary, Male, Middle Aged, Peritoneal Neoplasms mortality, Peritoneal Neoplasms secondary, Survival Analysis, Colonic Neoplasms pathology, Peritoneal Neoplasms drug therapy, Rectal Neoplasms pathology
- Abstract
Introduction: The aim of this study was to evaluate the results of an aggressive strategy in patients presenting peritoneal carcinomatosis (PC) from colorectal cancer with or without liver metastases (LMs) treated with cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC)., Patients and Methods: The population included 43 patients who had 54 CS+HIPEC for colorectal PC from 1996 to 2006. Sixteen patients (37%) presented LMs. Eleven patients (25%) presented occlusion at the time of PC diagnosis. Ascites was present in 12 patients (28%). Seventy-seven percent of the patients were Gilly 3 (diffuse nodules, 5-20 mm) and Gilly 4 (diffuse nodules>20 mm). The main endpoints were morbidity, mortality, completeness of cancer resection (CCR), and actuarial survival rates., Results: The CS was considered as CCR-0 (no residual nodules) or CCR-1 (residual nodules <5 mm) in 30 patients (70%). Iterative procedures were performed in 26% of patients. Three patients had prior to CS + HIPEC, 10 had concomitant minor liver resection, and 3 had differed liver resections (2 right hepatectomies) 2 months after CS + HIPEC. The mortality rate was 2.3% (1 patient). Seventeen patients (39%) presented one or multiple complications (per procedure morbidity = 31%). Complications included deep abscess (n = 6), wound infection (n = 5), pleural effusion (n = 5), digestive fistula (n = 4), delayed gastric emptying syndrome (n = 4), and renal failure (n = 3). Two patients (3.6%) were reoperated. The median survival was 38.4 months (CI, 32.8-43.9). Actuarial 2- and 4-year survival rates were 72% and 44%, respectively. The survival rates were not significantly different between patients who had CS + HIPEC for PC alone (including the primary resection) versus those who had associated LMs resection (median survival, 35.3 versus 36.0 months, P = 0.73)., Conclusion: Iterative CS + HIPEC is an effective treatment in PC from colorectal cancer. The presence of resectable LMs associated with PC does not contraindicate the prospect of an oncologic treatment in these patients.
- Published
- 2007
- Full Text
- View/download PDF
8. Omentoplasty in the prevention of anastomotic leakage after colonic or rectal resection: a prospective randomized study in 712 patients. French Associations for Surgical Research.
- Author
-
Merad F, Hay JM, Fingerhut A, Flamant Y, Molkhou JM, and Laborde Y
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anastomosis, Surgical, Female, Humans, Male, Middle Aged, Reoperation, Risk Factors, Treatment Outcome, Colectomy, Colonic Diseases surgery, Omentum surgery, Postoperative Complications prevention & control, Surgical Flaps
- Abstract
Objective: To investigate the role of omentoplasty (OP) in the prevention of anastomotic leakage after colonic or rectal resection., Summary Background Data: It has been proposed that OP--wrapping the omentum around the colonic or rectal anastomosis--reinforces intestinal sutures with the expectation of lowering the rate of anastomotic leakage. However, there are no prospective, randomized trials to date to prove this., Methods: Between September 1989 and March 1994, a total of 705 patients (347 males and 358 females) with a mean age of 66 +/- 15 years (range, 15-101) originating from 20 centers were randomized to undergo either OP (n = 341) or not (NO, n = 364) to reinforce the colonic anastomosis after colectomy. Patients had carcinoma, benign tumor, colonic Crohn's disease, diverticular disease of the sigmoid colon, or another affliction located anywhere from the right colon to and including the midrectum. Patients undergoing emergency surgery were not included. Random allotment took place once the resection and anastomosis had been performed, the surgeon had tested the anastomosis for airtightness, and the omental flap was deemed feasible. Patients were divided into four strata: ileo- or colocolonic anastomosis, supraperitoneal ileo- or colorectal anastomosis, infraperitoneal ileo- or colorectal anastomosis, and ileo- or coloanal anastomosis. The primary end point was anastomotic leakage. Secondary end points included intra- and extraabdominal related morbidity and mortality. Severity of anastomotic leakage was based on the rate of repeat operations and related deaths., Results: Both groups were comparable in terms of preoperative characteristics. Intraoperative findings were similar, except that there were significantly more septic operations and abdominal drainage performed in the NO group (p < 0.05 and p < 0.01, respectively). Thirty-five patients (4.9%) had postoperative anastomotic leakage, 16 in the OP group (4.7%) and 19 in the NO group (5.2%). There were 32 deaths (4.5%), 17 (4.9%) in the OP group and 15 (4.2%) in the NO group. Five patients with anastomotic leakage died (0.8%), 2 of whom had OP. There were 37 repeat operations (30%), 12 (6 in each group) for anastomotic leakage. Repeat operation was associated with fatal outcome in 14% of cases. The rate of these and the other intra- and extraabdominal complications did not differ significantly between the two groups., Conclusion: OP to reinforce colorectal anastomosis decreases neither the rate nor the severity of anastomotic failure.
- Published
- 1998
- Full Text
- View/download PDF
9. Shouldice inguinal hernia repair in the male adult: the gold standard? A multicenter controlled trial in 1578 patients.
- Author
-
Hay JM, Boudet MJ, Fingerhut A, Poucher J, Hennet H, Habib E, Veyrières M, and Flamant Y
- Subjects
- Follow-Up Studies, France epidemiology, Hernia, Inguinal epidemiology, Hernia, Inguinal prevention & control, Humans, Male, Middle Aged, Polypropylenes, Recurrence, Risk Factors, Stainless Steel, Suture Techniques, Sutures, Time Factors, Hernia, Inguinal surgery
- Abstract
Background: Hernia repair is the second most frequently performed operation in France and in the United States, the prevalence being 36 for every 1000 males. Lowering the recurrence rate by 1% would mean 1000 fewer operations for hernia repair per year in France., Methods: Between 1983 and 1989, 1578 adult males with a total of 1706 nonrecurrent inguinal hernias were prospectively and randomly allotted to undergo either a Bassini's repair, Cooper's ligament, or Shouldice repair with polypropylene or a Shouldice repair with stainless steel for determination of which technique was associated with the lowest recurrence rate. Fifty-nine hernia repairs were withdrawn after inclusion. Of the 1647 remaining hernias, 52.2% were indirect, 25.6% were direct, and 23.2% were combined. Patients were seen every 6 months for 3 years and then every year. Median follow-up was 5 years 8 months (range, 3 months-8.5 years)., Results: At 8.5 years, 5.6% of hernias were lost to follow-up. Ninety-seven hernia repairs failed, 50% during the first 2 years. The actuarial recurrence rate was 7.94% at 8.5 years. The Shouldice repair (stainless steel or polypropylene) was associated with fewer recurrences (6.1%) than either the Bassini's (8.6%) or Cooper's ligament repair (11.2%) technique (p < 0.001). This difference remained significant even when the maximal bias test was used. Fewer recurrences (5.9%) were observed with the stainless steel wire Shouldice repair than with polypropylene version (6.5%), but the difference was not significant., Conclusions: Shouldice hernia repair provides the patient with the best chances of nonrecurrence regardless of the anatomical type of hernia. The Shouldice hernia repair should be the gold standard for inguinal hernia repair in men and serves as the basis for comparison with all other techniques, be they prosthetic or laparoscopic.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.